Abstract:Following the publication of this article, a concerned reader drew to the Editor's attention that, for the Transwell migration and invasion assay experiments shown in Fig. 4B and D on p. 1806, an unexpected area of similarity was identified in terms of the cellular data comparing the two 'pc‐NC' data panels, where the results from differently performed experiments were intended to have been shown, although the areas immediately surrounding this area featured comparatively different distributions of cells. In addition, the western blots in this article were presented with atypical, unusually shaped and possibly anomalous protein bands in many cases. After having conducted an internal investigation, the Editor of Oncology Letters has reached the conclusion that the potentially anomalous data in this paper were unlikely to have arisen by coincidence. Therefore, on the grounds of a lack of confidence in the integrity of these data, the Editor has decided that the article should be retracted from the publication. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused, and thanks the concerned reader for drawing this matter to our attention. [Oncology Letters 16: 1801‐1808, 2018; DOI: 10.3892/ol.2018.8797]

Retraction Notice for Long-term Outcomes of 530 Esophageal Squamous Cell Carcinoma Patients with Minimally Invasive Ivor Lewis Esophagectomy. J Surg Oncol. 2018; 117:957-969.

Long-term Outcomes of 530 Esophageal Squamous Cell Carcinoma Patients with Minimally Invasive Ivor Lewis Esophagectomy

Retracted: The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma

RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

Retracted: Risk Factors of Benign Stricture of Anastomotic Stoma after Esophagectomy and Therapeutic Effect of Stent Implantation

RETRACTION: Effects of enhance recovery after surgery nursing program on the surgical site wound infection in patients undergoing laparoscopic hepatectomy for hepatocellular carcinoma: A meta-analysis

Retracted: Application of Amiodarone and Cedilan in the Treatment of Patients with Arrhythmia after Esophageal and Lung Cancer

Retracted: Clinical Efficacy of Single-Port Thoracoscopic Lobectomy versus Three-Port Thoracoscopic Lobectomy for Lung Cancer

Retracted: Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer

Retraction Notice to “30MO ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)”

Correction To: Comparison of Minimally Invasive Ivor Lewis Esophagectomy and Left Transthoracic Esophagectomy in Esophageal Squamous Cell Carcinoma Patients: a Propensity Score-Matched Analysis

Retracted: Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance

Retracted: Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery

Retracted: Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma

Retracted: The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma

Retracted: Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer

Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Retraction Note

Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate

Retracted: Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway

[Retracted] Downregulation of long non‐coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma